The enzymatic degradation of intramolecularly polymerized methacrylated dextran [dex-poly(MA)] and hydrogels based on methacrylated dextran was studied. Dex-poly(MA) was synthesized as a soluble model compound to investigate the enzymatic degradation of dextran hydrogels. After degradation of hydrogels and dex-poly(MA) by dextranase, the formed products were analyzed by gel permeation chromatography (GPC) and electrospray mass spectrometry (ES-MS). GPC analysis revealed that besides low-molecular-weight fractions (180−1100 Da) a soluble high-molecular-weight fraction (9−94 kDa) also was formed for both dextran hydrogels and dex-poly(MA). The high-molecular-weight products in degraded dextran hydrogels and dex-poly(MA) increased both in relative amount and in molecular weight with increasing degree of methacrylate substitution. This fraction most likely consisted of oligosaccharides bound to polymerized methacrylate groups. ES-MS showed that the low-molecular-weight fractions consisted of glucose, isomaltose and some larger unsubstituted oligosaccharides. The same products were formed after enzymatic degradation of native dextran. The enzymatic degradation of dex-poly(MA) as well as dextran hydrogels was described with kinetic models. Combination of enzyme kinetics, GPC and ES-MS lead to the conclusion that the enzymatic degradation can be divided in two processes. First, long unsubstituted chains with a length of probably about 18 or more glucopyranose residues are hydrolyzed at a similar rate and extent as native dextran. Second, the enzyme binds to unsubstituted chain segments of 6 to about 18 glucopyranose residues, which are hydrolyzed slower. Shorter unsubstituted chain segments are not enzymatically degraded.
No takes yet. Share an insight, caveat, or question.
Franssen et al. (1999) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: